Sun Pharma
What is USFDA's Form 483?
The US carries out regular inspections at offshore drug making units to ensure quality compliance. In a recent check, the US FDA has issued Form 483 to Sun Pharma Halol unit. Let's demystify Form 483
 "What is USFDA's Form 483?")
Sun Pharma to launch new oral lipid lowering drug under Brillo brand
Claims drug has a new mechanism of action compared to currently available lipid lowering agents, is indicated for people with inherited genetic disorder
 "Sun Pharma to launch new oral lipid lowering drug under Brillo brand")
USFDA rush after 2-year lull: 20-30% new products may be open to inspection
The last two years saw limited physical inspections due to travel restrictions during the pandemic
 "USFDA rush after 2-year lull: 20-30% new products may be open to inspection")
Sun Pharma's Halol unit gets 10 observations under USFDA's Form 483
Plant's OAI status is unchanged, hinting at status quo; Sun Pharma says will respond to observations within 15 days
 "Sun Pharma's Halol unit gets 10 observations under USFDA's Form 483")
Top headlines: SBI to raise up to $2 bn in FY23; Asian Paints Q4 net slips
Business Standard brings you the top headlines on Tuesday
 "Top headlines: SBI to raise up to $2 bn in FY23; Asian Paints Q4 net slips")
Sun Pharma slips over 2% after USFDA issues observations for Halol facility
In the past five days, the stock has fallen over 5 per cent. In comparison, the S&P BSE Sensex declined 3.75 per cent during the same period
 "Sun Pharma slips over 2% after USFDA issues observations for Halol facility")
Aurobindo, Sun Pharma, Jubilant recall products in US market: USFDA
Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons
 "Aurobindo, Sun Pharma, Jubilant recall products in US market: USFDA")
Cipla, Ipca Lab, Zydus Life to benefit most from drug price rise: Analysts
The recent price hike, analysts said, brings some respite for the industry facing multiple headwinds such as steep raw inflation, price erosion in the US market and higher freight costs.
 "Cipla, Ipca Lab, Zydus Life to benefit most from drug price rise: Analysts")
Sun Pharma, Ranbaxy Inc sign pact with 2 plaintiff groups to settle claims
Sun Pharma said has disputed the claims of the plaintiffs and defended these matters vigorously
Sensex rebounds 1,059 pts from day's low, ends 697 pts up; RIL leaps 2.5%
CLOSING BELL: Tech M, Tata Motors, BPCL, ITC, JSW Steel, PowerGrid, Bajaj Auto, Infosys, TCS, Bajaj Finserv, Bharti Airtel, Wipro and IndusInd Bank were the other gainers
 "Sensex rebounds 1,059 pts from day's low, ends 697 pts up; RIL leaps 2.5%")
Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo
Sun Pharma said it will pay Rs 5.32 crore for the stake
Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug
Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.
 "Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug")
Strong specialty sales and volumes keep it sunny for Sun Pharma
Rerating on the cards; the domestic business is expected to outperform
Here's why Vinay Rajani of HDFC Securities is bullish on GSFC, Sun Pharma
The technical analyst expects the Nifty to turn bearish below 16,555; whereas on the upside sees resistance around 16,927 and 17,040 levels.
 "Here's why Vinay Rajani of HDFC Securities is bullish on GSFC, Sun Pharma")
Sensex rises for 2nd day, surges 1,223 pts; Nifty tops 16,300; RIL zooms 5%
CLOSING BELL: Ukrainian President Volodymyr Zelenskyy's reported statement that his country has cooled down on the question of a NATO membership calmed investor nerves
 "Sensex rises for 2nd day, surges 1,223 pts; Nifty tops 16,300; RIL zooms 5%")
Stocks to Watch: MTNL, Sun Pharma, Airlines, Adani Ports, Bharat Forge
MTNL is in focus as the Centre is considering relaxing some norms that led to the failure in attracting bids for assets of BSNL and MTNL as they look to restart the auction for their non-core assets.
 "Stocks to Watch: MTNL, Sun Pharma, Airlines, Adani Ports, Bharat Forge")
Investors' wealth jumps over Rs 2.51 trillion as stocks rebound
Sun Pharma the biggest gainer among Sensex firms with a jump of 3.99 per cent, followed by TCS, NTPC, Wipro, Tech Mahindra, Dr Reddy's, UltraTech Cement and Infosys
 "Investors' wealth jumps over Rs 2.51 trillion as stocks rebound")
Stocks to Watch: Aurobindo, Sun Pharma, Future Retail, Vedanta, Voda Idea
Shares of Adani Power are likely to be in focus as the company received a favourable verdict from the Supreme Court against power discoms in Rajasthan.
 "Stocks to Watch: Aurobindo, Sun Pharma, Future Retail, Vedanta, Voda Idea")
Aurobindo, Sun Pharma recall products in US market for defaulting norms
Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms.
Pharma industry likely to grow to $130 billion by 2030: Industry leaders
'As India becomes an increasingly more important component for the global supply chain, that should benefit the industry going forward,' Sun Pharma Managing Director Dilip Shanghvi said
 "Pharma industry likely to grow to $130 billion by 2030: Industry leaders")
